Prognostic Value of Right Ventricular Myocardial Strain in Patients With Acute Myocardial Infarction
1 other identifier
observational
200
1 country
1
Brief Summary
For a long time, the right ventricle has been the "forgotten chamber", but with the deepening of people's understanding of the disease, right ventricular dysfunction has become an important factor to evaluate the disease progression and late prognosis of patients with AMI. Right ventricular myocardial strain derived from two-dimensional speckle tracking echocardiography is a new method for early evaluation of regional and global right ventricular systolic function, and its repeatability is much higher than that of LVEF. Acute inferior myocardial infarction is often caused by occlusion of the proximal middle segment of the right coronary artery. Many studies have confirmed that RVMS is an independent predictor of poor prognosis in patients with AIMI. However, 60% of the right ventricular systolic function is contributed by the left ventricle and interventricular septum, and the left anterior descending branch and the left circumflex branch are the main sources of blood supply to the left ventricle and interventricular septum, so in theory, non-RCA occlusion can also lead to varying degrees of right ventricular dysfunction. However, there are few studies on the role of RVMS in predicting the prognosis of AMI patients caused by non-RCA occlusion. Therefore, the purpose of this study is to prospectively study the value of dynamic changes of RVMS in predicting the prognosis of patients with acute myocardial infarction with different infarct-related vessels, in order to provide more clinical reference information for the diagnosis and treatment of AMI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 31, 2022
CompletedFirst Posted
Study publicly available on registry
June 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedJune 24, 2022
March 1, 2022
2.7 years
May 31, 2022
June 20, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Major Adverse Cardiovascular Events
Nonfatal stroke, nonfatal myocardial infarction, target vessel requiring revascularization, death
2 years
Study Arms (2)
acute myocardia infarction patients with right coronary artery occlusion
acute myocardia infarction patients with non-right coronary artery occlusion
Interventions
Two-dimensional speckle tracking echocardiography is used to assess cardiac function in all enrolled patients
Eligibility Criteria
patients with acute myocardial infarction undergoing primary percutaneous coronary intervention are included.
You may qualify if:
- Males and females were between 35 and 85 years old;
- coronary artery disease underwent emergency PCI for NSTEMI or primary PCI for STEMI;
- coronary artery type was right coronary dominance;
- regular follow-up for 2 year.
You may not qualify if:
- Patients who cannot complete 2D speckle tracking imaging;
- patients with severe valvular disease, cardiomyopathy, or congenital heart disease; severe liver and kidney insufficiency or chronic respiratory disease;
- previous PCI or CABG;
- coronary artery type: Left crown dominance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2022
First Posted
June 3, 2022
Study Start
October 1, 2021
Primary Completion
May 30, 2024
Study Completion
October 30, 2024
Last Updated
June 24, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share